Projects funded by the NCN
Dual-Target Compounds Modulating EAAT2 and Kv7.2/3 Channels: A Rational Strategy Toward Novel Antiseizure and Antinociceptive Pharmacotherapy.
2025/57/B/NZ7/02206
Keywords:
EAAT2 Kv7.2/3 channels dual-target compounds antiseizure agents antinociceptive therapy rational drug design epilepsy neuropathic pain glutamate transporters potassium channel modulators.
Descriptors:
- ST5_15:
- NZ7_07:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 19
Call: OPUS 29 - announced on 2025-03-17
Amount awarded: 2 990 873 PLN
Project start date (Y-m-d): 2026-02-13
Project end date (Y-m-d): 2030-02-12
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.